Skip to main content
PMC home page
CMAJ : Canadian Medical Association Journal logoLink to CMAJ : Canadian Medical Association Journal
. 1989 Feb 15;140(4):405–411.

Primary lipoprotein-lipase-activity deficiency: clinical investigation of a French Canadian population.

C Gagné 1, L D Brun 1, P Julien 1, S Moorjani 1, P J Lupien 1
PMCID: PMC1268664  PMID: 2914262

Abstract

We examined 56 French Canadians, aged 1 week to 54 years, from eastern Quebec who were referred to the Laval University Lipid Research Centre and in whom coincidental finding (in 46% of the cases), abdominal pain (in 32%) or family screening (in 22%) led to the diagnosis of primary lipoprotein-lipase-activity deficiency (familial hyperchylomicronemia). Half of the patients had one or more of the following signs: lipemia retinalis, eruptive xanthomas, splenomegaly and hepatomegaly; the plasma triglyceride concentrations were significantly higher (greater than 40 mmol/L) among these patients than among those without clinical signs (mean 21.7 [standard deviation 13.5] mmol/L). The prevalence rate of this disorder was 30 times higher than the previously published rate and was highest in the counties of Charlevoix and Saguenay-Lac-St-Jean (200 and 100 cases per million respectively) because of the distinct demographic history of these areas. Because of a founder effect an autosomal recessive gene involved in lipoprotein-lipase expression or activation has probably been disseminated among this isolated French Canadian population.

Full text

PDF
411

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Berger G. M. Clearance defects in primary chylomicronemia: a study of tissue lipoprotein lipase activities. Metabolism. 1986 Nov;35(11):1054–1061. doi: 10.1016/0026-0495(86)90043-0. [DOI] [PubMed] [Google Scholar]
  2. Bouchard G., Laberge C., Scriver C. R. La tyrosinémie héréditaire et le rachitisme vitamino-dépendant au Saguenay. Une approche génétique et démographique. Union Med Can. 1985 Aug;114(8):633–636. [PubMed] [Google Scholar]
  3. Breckenridge W. C., Little J. A., Steiner G., Chow A., Poapst M. Hypertriglyceridemia associated with deficiency of apolipoprotein C-II. N Engl J Med. 1978 Jun 8;298(23):1265–1273. doi: 10.1056/NEJM197806082982301. [DOI] [PubMed] [Google Scholar]
  4. Brun L. D., Gagné C., Rousseau C., Moorjani S., Lupien P. J. Severe lipemia induced by tamoxifen. Cancer. 1986 Jun 1;57(11):2123–2126. doi: 10.1002/1097-0142(19860601)57:11<2123::aid-cncr2820571106>3.0.co;2-2. [DOI] [PubMed] [Google Scholar]
  5. Brunzell J. D., Iverius P. H., Scheibel M. S., Fujimoto W. Y., Hayden M. R., McLeod R., Frolich J. Primary lipoprotein lipase deficiency. Adv Exp Med Biol. 1986;201:227–239. doi: 10.1007/978-1-4684-1262-8_20. [DOI] [PubMed] [Google Scholar]
  6. Brunzell J. D., Miller N. E., Alaupovic P., St Hilaire R. J., Wang C. S., Sarson D. L., Bloom S. R., Lewis B. Familial chylomicronemia due to a circulating inhibitor of lipoprotein lipase activity. J Lipid Res. 1983 Jan;24(1):12–19. [PubMed] [Google Scholar]
  7. Connelly P. W., Maguire G. F., Hofmann T., Little J. A. Structure of apolipoprotein C-IIToronto, a nonfunctional human apolipoprotein. Proc Natl Acad Sci U S A. 1987 Jan;84(1):270–273. doi: 10.1073/pnas.84.1.270. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Fallat R. W., Vester J. W., Glueck C. J. Suppression of amylase activity by hypertriglyceridemia. JAMA. 1973 Sep 10;225(11):1331–1334. [PubMed] [Google Scholar]
  9. Gagne C., Brun D., Moorjani S., Lupien P. J. Hyperchylomicronémie familiale: étude de l'activité lipolytique dans une famille. Union Med Can. 1977 Mar;106(3):333–338. [PubMed] [Google Scholar]
  10. Gagné C., Auger P. L., Moorjani S., Brun D., Lupien P. J. Effect of hyperchylomicronemia on the measurement of hemoglobin. Am J Clin Pathol. 1977 Nov;68(5):584–586. doi: 10.1093/ajcp/68.5.584. [DOI] [PubMed] [Google Scholar]
  11. Gagné C., Moorjani S., Brun D., Toussaint M., Lupien P. J. Heterozygous familial hypercholesterolemia. Relationship between plasma lipids, lipoproteins, clinical manifestations and ischaemic heart disease in men and women. Atherosclerosis. 1979 Sep;34(1):13–24. doi: 10.1016/0021-9150(79)90101-1. [DOI] [PubMed] [Google Scholar]
  12. HAVEL R. J., EDER H. A., BRAGDON J. H. The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum. J Clin Invest. 1955 Sep;34(9):1345–1353. doi: 10.1172/JCI103182. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Hobbs H. H., Brown M. S., Russell D. W., Davignon J., Goldstein J. L. Deletion in the gene for the low-density-lipoprotein receptor in a majority of French Canadians with familial hypercholesterolemia. N Engl J Med. 1987 Sep 17;317(12):734–737. doi: 10.1056/NEJM198709173171204. [DOI] [PubMed] [Google Scholar]
  14. Hoeg J. M., Osborne J. C., Jr, Gregg R. E., Brewer H. B., Jr Initial diagnosis of lipoprotein lipase deficiency in a 75-year-old man. Am J Med. 1983 Nov;75(5):889–892. doi: 10.1016/0002-9343(83)90423-0. [DOI] [PubMed] [Google Scholar]
  15. Laberge C. Population genetics and health care delivery: the Quebec experience. Adv Hum Genet. 1976;6:323–374. doi: 10.1007/978-1-4615-8264-9_5. [DOI] [PubMed] [Google Scholar]
  16. Laurell C. B. Electroimmuno assay. Scand J Clin Lab Invest Suppl. 1972;124:21–37. doi: 10.3109/00365517209102748. [DOI] [PubMed] [Google Scholar]
  17. Maguire G. F., Little J. A., Kakis G., Breckenridge W. C. Apolipoprotein C-II deficiency associated with nonfunctional mutant forms of apolipoprotein C-II. Can J Biochem Cell Biol. 1984 Sep;62(9):847–852. doi: 10.1139/o84-108. [DOI] [PubMed] [Google Scholar]
  18. Sadan N., Drucker M. M., Arber I., Joseph D., Franco S., Shapiro M. S. Type I hyperlipoproteinemia in an 8-day-old infant. J Pediatr. 1977 May;90(5):775–777. doi: 10.1016/s0022-3476(77)81247-x. [DOI] [PubMed] [Google Scholar]
  19. Saku K., Cedres C., McDonald B., Hynd B. A., Liu B. W., Srivastava L. S., Kashyap M. L. C-II anapolipoproteinemia and severe hypertriglyceridemia. Report of a rare case with absence of C-II apolipoprotein isoforms and review of the literature. Am J Med. 1984 Sep;77(3):457–462. doi: 10.1016/0002-9343(84)90102-5. [DOI] [PubMed] [Google Scholar]
  20. Steffes M. W., Freier E. F. A simple and precise method of determining true sodium, potassium, and chloride concentrations in hyperlipemia. J Lab Clin Med. 1976 Oct;88(4):683–688. [PubMed] [Google Scholar]

Articles from CMAJ: Canadian Medical Association Journal are provided here courtesy of Canadian Medical Association

RESOURCES